|
||
By

From the * National Jewish Medical and Research Center, Division of Basic Sciences, Department of
Pediatrics, Denver, Colorado 80206; and the
University of Colorado Health Science Center,
Department of Immunology, Denver, Colorado 80220
| |
Abstract |
|---|
|
|
|---|
Allelic exclusion is established in development through a feedback mechanism in which the assembled immunoglobulin (Ig) suppresses further V(D)J rearrangement. But Ig expression
sometimes fails to prevent further rearrangement. In autoantibody transgenic mice, reactivity of
immature B cells with autoantigen can induce receptor editing, in which allelic exclusion is
transiently prevented or reversed through nested light chain gene rearrangement, often resulting in altered B cell receptor specificity. To determine the extent of receptor editing in a normal, non-Ig transgenic immune system, we took advantage of the fact that
light chain genes
usually rearrange after
genes. This allowed us to analyze
loci in IgM
+ cells to determine
how frequently in-frame
genes fail to suppress
gene rearrangements. To do this, we analyzed recombined V
J
genes inactivated by subsequent recombining sequence (RS) rearrangement. RS rearrangements delete portions of the
locus by a V(D)J recombinase-dependent mechanism, suggesting that they play a role in receptor editing. We show that RS
recombination is frequently induced by, and inactivates, functionally rearranged
loci, as
nearly half (47%) of the RS-inactivated V
J
joins were in-frame. These findings suggest that
receptor editing occurs at a surprisingly high frequency in normal B cells.
| |
Introduction |
|---|
|
|
|---|
The fact that virtually all B cells express a single H and L
chain prompted many studies to elucidate the underlying mechanism. One process that clearly contributes to
allelic exclusion is the imprecision of V(D)J rearrangement
that generates a maximum of one in-frame rearrangement
per three attempts (1), but more active feedback processes
are also involved. Classic studies showing the ability of a H
chain transgene (2, 3) or an L chain transgene (4, and for
review see reference 5) to mediate feedback suppression of
H and L chain rearrangements, respectively, established important paradigms that have been widely accepted. But in
the case of L chain allelic exclusion, this paradigm was
weakened by an increasing number of "exceptions", in
which ongoing L chain rearrangement occurred despite expression of functional
chain (6). Studies with autoantibody transgenic (Tg)1 mice suggested that many of the exceptions to the feedback regulation model of L chain allelic
exclusion could be explained by postulating self-tolerance-
induced receptor editing (10). In addition, recent in
vitro studies (16) and analyses of autoantibody Ig knock-in mice (19, 20) have shown that L chain gene receptor editing can be an important mechanism of B cell
tolerance. Despite these findings, it is unclear how frequently receptor editing is used for tolerance induction in
normal, non-Ig Tg autoreactive B cells, in part because the
extent of autoreactivity in the preselected B cell repertoire
is unknown.
The organization of the
locus, with arrangement of V
genes in both sense and antisense transcriptional orientations, the absence of D region gene segments, and the presence of several J
gene segments facilitates sequential, nested
V
-to-J
rearrangement attempts (for review see reference
21). In developing B cells, these secondary rearrangements
can both rescue receptor expression in cells that fail to
assemble in-frame L chains (1, 22) and rescue autoreactive B
cells from tolerance elimination by replacing rearranged
genes with new ones that alter specificity (for review see
reference 23). Another way that the organization of the
locus promotes receptor editing is suggested by the existence of the conserved element known as recombining sequence (RS) in the mouse (or the homologous "
deleting
element" in humans; reference 24). RS is located ~25 kb
downstream of the C
exon (25) and has no coding function (26), but undergoes V(D)J recombinase-dependent rearrangement that inactivates the
locus by deletional rearrangements in cis (26) (see Fig. 1). In an autoantibody
knock-in model system, RS rearrangements can inactivate
functional
genes (20), but the extent of RS-mediated receptor editing in normal B cells remains unknown.
|
One approach to estimate the extent of receptor editing
in normal B cells is to analyze V(D)J recombinational remnants that are the predicted residue of editing. In mouse B
cells, which contain both
and
L chain loci,
gene rearrangement almost always occurs after
rearrangement (for
review see references 29, 30). Thus, if an appropriate
gene
is not assembled, rearrangement at the
locus often follows.
In
+ B cells, RS rearrangements usually have deleted the
C
loci (27, 28, 31) either by recombining to V
s, through
the well characterized heptamer-nonamer recombination
signal sequences (Fig. 1 B), or to heptamer sites in the
J
-C
intron (Fig. 1 C) (27, 28, 32). Besides destroying the
function of the
locus, this latter mode of RS recombination has two important effects: first, unlike nested V
J
recombinations, it eliminates the C
-associated cis-acting enhancer elements that are critical for V
J
expression and
rearrangement (33), and second, it retains any V
J
join
that was previously adjacent to C
. This physiological
knockout of regulatory sequences required for
gene rearrangement thus "freezes" the locus, allowing an analysis of
the V
J
gene that was assembled adjacent to the C
exon
just before RS and
gene rearrangement.
In this study, we have isolated such V
J
joins from a
large number of individual IgM+
+ B cells and determined
their nucleotide sequences in order to ascertain the extent
to which RS inactivates functional
genes in a normal,
non-Ig Tg immune system. The results indicate that in
normal IgM+ B cells RS-mediated receptor editing is induced by and frequently inactivates functionally rearranged
genes, probably because of immune tolerance.
| |
Materials and Methods |
|---|
|
|
|---|
Mice.
Mice homozygous for the targeted deletion of the J
-
C
locus (JC
D/JC
D; a gift from D. Huszar, GenPharm International, San Jose, CA; reference 33) were maintained under
specific pathogen-free conditions in the animal care facility at National Jewish Medical and Research Center. JC
D/JC
D mice
were bred with B10.D2nSn/J mice to generate B10.D2nSn/
J-JC
D/+ mice (JC
D/+), which were used at 6-8 wk of age.
Cell Sorting and Genomic DNA Isolation.
Splenic cells from JC
D/+ mice were isolated and stained with goat anti-mouse
IgM-PE (Caltag Labs., San Francisco, CA) and goat anti-mouse
-FITC (Fisher Scientific Co., Pittsburgh, PA) and sorted on an
ELITE flow cytometer (Coulter Corp., Miami, FL) to collect
IgM+
+ B cells. Genomic DNA was isolated from cells by overnight proteinase K digestion in lysis buffer (100 mM NaCl, 10 mM Tris-Cl, pH 8, 25 mM EDTA, 0.5% SDS) at 55°C, followed
by phenol/chloroform extraction and EtOH precipitation.
Analysis of Direct PCR Amplified Ig Rearrangements.
Genomic DNA from sorted cells was used as a template to amplify V
J
-intron-RS rearrangements. As shown in Fig. 1, primers A (degenerate V
framework region [FWR]3; reference 37) and B (RS
-101, 5' ACATGGAAGTTTTCCCGGGAGAATATG 3') amplified a product of ~1,450 bps (for J
5) using an amplification
profile of 1 min at 94°C, 1 min at 58°C and 1 min at 72°C for
30-35 cycles. The resulting V
J
5-intron-RS products were gel
isolated and cloned into the TA II vector (Invitrogen, Carlsbad,
CA) and colonies were screened by hybridization using the IVS
probe (1). PCR clones were sequenced by the dideoxy termination method (Sequenase; United States Biochemical Corp.,
Cleveland, OH) using vector-specific forward and reverse primers, as well as antisense J
5-specific (5' CTAACATGAAAACCTGTGTCTTACACA 3') and RS-specific (5' AAAGCTACATTAGGGCTCAAATCTGA 3') primers. Both DNA strands
from the PCR clones were sequenced over the V
J
joins to
verify the reading frame.
Production of
+ Hybridomas.
D/+ mice were cultured in DMEM supplemented with 10%
fetal bovine sera plus 50 µg/ml LPS (E. coli LPS; Sigma Chemical
Co., St. Louis, MO) for 3 d, then fused with NSO-bcl2 (38) myeloma cells for fusion 1 or SP2/0 (39) myeloma cells for fusions 2 through 5. Hybridoma supernatants were screened by ELISA for
secretion of micrometer/liter Ig and the lack of
Ig secretion.
Analysis of Hybridoma Ig Rearrangements.
Hybridoma genomic DNA was digested with EcoRI or BamHI, then fractionated on 0.8% agarose gels, blotted to nylon membrane, and hybridized with the RS 0.8 (27) or IVS probes (Fig. 1 A). V
-RS rearrangements were identified by genomic Southern blot analysis using
the RS probe and/or by PCR amplification using primer A and
primer B to yield a PCR product of ~255 bps. V
J
-intron-RS rearrangements were identified by genomic Southern blot analysis using both the RS and IVS probes and/or by PCR amplification
using primer C (J
intron, 5' CTGACTGCAGGTAGCGTGGTCTTCTAG 3') and primer B, and amplified for isolation and
sequencing using primers A and B. The resulting products were
isolated from 1.8% low-melt agarose gels, cycle sequenced directly (Dye Terminator Cycle Sequencing Ready Reaction kit;
PE Applied Biosystems, Norwalk, CT) and analyzed using an
ABI 377 DNA Sequencer (PE Applied Biosystems). To obtain near full-length sequences of hybridoma 1-2A7, 1-2E11, 2-2H11, 3-15D6, 3-15C4 and 3-17B10 V
genes, a consensus FWR1
oligo (amino acids
1 through 8; 5' GGTGACATTGTGCTGACCCAGTCTCCA 3') was used with antisense J
-intron oligos for PCR amplification, followed by cycle sequencing of the
products. For hybrids 1-3E8, 2-15E11, 3-7G5, 4-1D2, 1-10A11
and 1-11A4, V
leader specific oligos (Ig Prime kit; Novagen,
Madison, WI) were used for amplification.
Cloning and Expression of V(D)J Rearrangements for Analysis of H/
L
Chain Pairing.
J
-RS rearrangements from hybridoma 2H11 were genomically cloned as
previously described (40), with the modifications that
Zap
(Stratagene, La Jolla, CA) was the cloning vector and the RS and
IVS probes were used to screen clones for the V
J
-RS rearrangement. The 6.5-kb EcoRI fragment containing the V(D)J rearrangement and the 4.0-kb EcoRI-XbaI fragment containing
the V
J
rearrangement were gel isolated and ligated to pRµSal,
a Cµ expression vector (41) and pSV2-neo-C
, a C
expression
vector (42) respectively. The H chain from hybridoma 15E11
was cloned by PCR amplification using a leader intron oligo (5'
GAACTGGCAGGACCTGAGGTGAAAATGACA 3') and an
oligo that spanned the XbaI site downstream of JH4 (5' CAGGCTCCACCAGACCTCTCTAGA 3'). The resulting product
was digested with EcoO109I and XbaI and ligated into EcoO109I
and XbaI digested 8-1Cµ (40), a Cµ expression vector. The
V
J
-RS rearrangement from hybridoma 15E11 was also cloned
by PCR using a leader intron oligo (5' TGGAATTCCAGGTTCTACTGGAGACATTGT-3') and an oligo which spanned
the XbaI site downstream of J
5 (5' ACGAATTCGTCTAGAAGACCACGCTACCT 3'). The resulting product was digested with EcoRI and subcloned into a shuttle vector containing
V
21C leader and promoter elements. An XbaI fragment that
contained the promoter elements, leader, and the 15E11 V
J
rearrangement was isolated and cloned into the XbaI site in pSV2-neo-C
(42). The 2H11 and 15E11 H and L chain constructs
were then cotransfected into SP2/0 myeloma cells and selected
for expression of IgM
as previously described (40).
IgM
ELISA for Analysis of H/
L Pairing.
expression by ELISA. In brief, goat anti-mouse IgM
(Southern Biotechnology Associates, Inc., Birmingham, AL) was
diluted in PBS, coated onto 96-well Immulon 2HB plates (Dynex Technologies, Inc., Chantilly, VA) and incubated at
room temperature for 3 h. Plates were washed five times with
PBS/Tween 20, then incubated with blocking buffer (PBS, 0.5%
BSA, 0.4% Tween 20) for 1 h at room temperature. Serial dilution of transfectoma and parental hybridoma supernatants were
added and incubated at room temperature for 2 h. Plates were
washed and horseradish peroxidase-conjugated goat anti-mouse
(Southern Biotechnology Associates, Inc.) was added and incubated for 2 h. After a final wash, the chromogenic substrate 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (Sigma Chemical
Co.) was added in McIlvain's buffer (84 mM Na2PO4/48 mM citrate, pH 4.6) with 0.005% H2O2 and OD 410 nm was read using an automated plate reader (Dynatech, Alexandria, VA). Transfectoma and hybridoma antibody concentrations were estimated by
comparison to a TEPC 183 (µ
) standard curve.
| |
Results |
|---|
|
|
|---|
To determine
the extent to which RS recombination inactivates functional, in-frame V
J
joins in the preimmune B cell repertoire, IgM+
+ splenic B cells were isolated by fluorescence
activated cell sorting and their genomic DNA was analyzed
by the PCR strategy outlined in Fig. 1 C. This cell sorting
strategy should exclude from the template pool cells that
are
+, H chain isotype switched, surface (s)Ig
, or cells of
a sIglo, germinal center phenotype. In a second series of experiments, IgM
secreting hybridomas were isolated and
their
loci analyzed in detail. To simplify these analyses, all
B cells analyzed were heterozygous for a targeted deletion
of the J
-C
locus (JC
D/+), in which only a single
locus and RS allele could rearrange (33). The potential
gene and RS element rearrangements are depicted in Fig. 1.
Cells Reveals Frequent Receptor Editing.
Genomic DNA from sorted IgM
cells was used as template
for a PCR using a panspecific V
FWR 3 oligonucleotide
primer, which recognizes ~80% of V
genes (37), together
with an RS-specific primer to amplify V
J
-intron-RS rearrangements (Fig. 1 C, primers A and B). V
J
-intron-RS
rearrangements containing V
genes rearranged to each of
the four functional J
genes were detected by PCR amplification and Southern blotting (data not shown), but V
J
5-intron-RS rearrangements were most abundant, in part
because their smaller size promoted preferential amplification. Amplified V
J
5-intron-RS rearrangements were gel-purified and cloned, and a total of 52 clones were sequenced across both the V
J
and the J
-intron-RS joins (Fig. 2).
These two different recombination joins, present on each
PCR product analyzed, provided markers for uniqueness.
PCR products that were identical to one another, or that
differed by just one nucleotide, were assumed to represent
repeated isolates derived from the same initial template (i.e.,
derived from a single B cell clone). This represents an underestimate because the single base changes could have reflected
real differences and because it was possible that some of the
apparent repeats were independent events that happened to
have identity in the portions of the genes studied, but not in
upstream portions of the V genes. In this sample, at least 37 of the 52 clones represented independent events. Analysis of the V
J
join sequences allowed an assessment of the potential prior functionality of the V
J
5 joins just upstream of
intron-RS rearrangements. Surprisingly, 15 of the 37 clones
(41%) contained V
J
joins that were in-frame (Fig. 2), and
if the apparent repeats were not excluded 23 out of 52 (44%)
were in-frame.
|
To verify the analysis of the PCR-amplified V
J
-intron-RS rearrangements and to increase the sample size, an independent sampling of V
J
-intron-RS rearrangements
was derived from JC
D/+ splenocytes in the form of B
cell hybridomas. A total of 133 IgM
-expressing hybrids
were obtained from five separate fusions and their
locus rearrangements were analyzed. Genomic Southern blot and
PCR analysis revealed that at least 74% of the
+ hybrids
(99 out of 133) had inactivated the wild-type
locus by
RS rearrangements (Table 1), a value in accord with previous estimates (31, 34). Two hybridomas apparently had undergone inversional V
-RS rearrangements, as they had
unique restriction fragments that retained the C
locus as
revealed by the intron (IVS) probe (data not shown), but
scored positive in a V
-RS PCR (Fig. 1 B). Approximately
25% (26 out of 99) of the hybridomas with RS rearrangements had J
-intron-RS joins (Table 1), as detected with
primers B and C (Fig. 1 C). Genomic Southern blot analysis of 18 out of 20 hybrids scoring PCR positive for J
-
intron-RS rearrangements demonstrated that the RS rearrangements colocalized with EcoRI restriction fragments
hybridizing with the IVS probe (data not shown), thus independently confirming the V
J
-intron-RS rearrangement phenotype. V
J
-intron-RS rearrangements from
individual hybridomas were PCR amplified and directly
sequenced, rather than cloned, a procedure that diminishes
potential Taq polymerase-generated mutations. Like the
V
J
-intron-RS PCR clones, most of the V
J
-intron-RS loci from hybridomas used J
5, although four hybridomas had rearrangements to upstream J
s, including one to
J
2 and three to J
4, suggesting that developing B cells do
not frequently undergo RS rearrangement until all of the
J
s are rearranged. Sequence analysis over both the V
J
and intron-RS joins clearly showed that each cell line had a
unique sequence at the V
J
join and that, remarkably, 12 of 20 (60%) of the V
J
joins were in-frame (Fig. 3 A).
|
|
V
J
-intron-RS rearrangements were clearly diverse because at least 32 different V
genes representing 11 of the 19 V
families were identified
among the 57 independent V
J
-intron-RS loci analyzed (data not shown). This value of V
gene representation in
the V
J
-intron-RS loci analyzed is most likely an underestimate of the diversity because the 5' PCR primer lies in
FWR3 and yields only a short stretch of V
gene sequence
for interclonal comparison. Despite this limitation, multiple
genes were observed within particular V
gene families.
For example, within the V
4/5 family, at least 11 different
genes were represented among the 14 in-frame and 7 out-of-frame joins (data not shown). In addition, V
genes were sometimes found repeatedly in independent V
J
-intron-RS rearrangements and there was considerable overlap in
usage among hybridoma and PCR clone sequences. 13 of
the hybridomas used V
genes that were observed in the
direct PCR-derived clones, whereas 6 hybridomas expressed distinct V
genes that were members of families
observed in the PCR clone sample and 1 hybridoma expressed a V
32 gene, a V
family not seen in the PCR
clone samples (Figs. 2 and 3 and data not shown).
The sequences of the J
-intron-RS
joins in both the PCR clones (Fig. 2) and hybridomas (Fig.
3 B) were quite varied and were dominated by deletions at
both sides of the joins, as up to nine nucleotides were missing from either the J
-intron or RS heptamer-flanking sequences. There did appear to be a bias for a particular join (e.g., clone 4, Fig. 2 A), which was observed to be associated with 13 independent V
J
rearrangements. Two of
the intron-RS joins contained P nucleotides and one contained N-region addition nucleotides, consistent with findings described previously (7, 43).
Antibodies for Analysis of H/
L Pairing
and Antigen Specificity.
To determine if the high frequency
of in-frame V
J
rearrangements silenced by intron-RS recombination was due to the inability of H chains to pair with
their
L chains, the V(D)J and V
J
rearrangements from
hybridomas 2H11 and 15E11 were cloned into Cµ and C
expression vectors, respectively. These H and L chain constructs were cotransfected into SP2/0 myeloma cells to generate transfectoma clones. Analysis of transfectoma supernatants by IgM
sandwich ELISA revealed that the in-frame
L chains were able to pair with their hybridoma H chains
(Fig. 4), suggesting that ongoing RS rearrangement was not
due to the inability of H/L chain pairing. The specificity of
the µ
transfectoma antibodies remains unknown, however.
Attempts in flow cytometry assays to detect recombinant antibody binding to the surfaces of bone marrow cells were
unsuccessful (data not shown).
|
| |
Discussion |
|---|
|
|
|---|
In this report we examined the DNA sequences of V
J
joins located upstream of intronic-RS rearrangements in
normal, non-Ig Tg B cells to determine the extent to
which RS-mediated recombination silences functionally rearranged
genes. Nearly half of all V
J
joins inactivated by
RS recombination were in-frame (27 out of 57). This high
frequency is clearly incompatible with a strict feedback suppression model of L chain allelic exclusion, which predicts
no in-frame V
J
joins upstream of the RS rearrangements. More strikingly, this high frequency is also significantly
higher than 33%, the percentage of in-frame joins expected
from random V
J
rearrangement, indicating that productive V
J
rearrangements actively induce intron-RS rearrangements. The data also demonstrate a physiological role
for the RS element in normal B cell development
the inactivation of functionally rearranged
genes.
To understand why we conclude that the RS rearrangements were actively induced by functional
L chains, consider the extreme hypothetical cases of mice in which all
gene rearrangements result in either autoreactive B cell receptors or nonproductive
chains (Table 2). If V
-to-J
and RS rearrangements proceed randomly, albeit with different relative frequencies, then in either case V
J
joins
located upstream of intronic-RS rearrangements should be
in-frame at a maximum frequency of one out of three. To
significantly exceed this frequency, in-frame V
J
joins
must stimulate the relative rate of (intronic) RS rearrangement. This argument applies to our data because the observed frequency of in-frame joins, 47.4%, is significantly
higher than one out of three (P < 0.04, single sample test
of a proportion based on a normal approximation). Since it
is exceedingly unlikely that the stimulus for increased in-frame rearrangements is mediated by anything other than
protein, and because
chains can probably only be perceived by the signaling machinery of B cells through their
association with H chains, we conclude that functional
chains actively stimulate the rate of RS rearrangement
based on B cell receptor antigenic specificity. These data
also predict that in mice in which the C
exon is inactivated, but surrounding cis-acting elements are left intact,
V
J
rearrangement should be extensive, whereas RS rearrangement should be reduced. This is in fact the experimental observation (44).
|
The statistical argument also excludes the possibility that
a high frequency of rearrangeable V
pseudogenes, L
chains that fail to pair with H chains, or a role for positive
selection is responsible for our results. Furthermore, complete sequencing of the coding regions from all the in-frame V
J
rearrangements derived from
+ hybridomas
revealed no stop codons or other obvious defects that would have precluded function (Fig. 3 A). It is also unlikely that frequent aberrant H/L chain pairing is responsible for the high frequency of in-frame V
J
joins in the
V
J
-intron-RS rearrangements, as demonstrated by the
ability of H/
L chains from two hybridomas to pair (Fig.
4). Moreover, there are few examples of L chains that fail
to pair with H chains and most experiments suggest that virtually all random H/L pairs can associate (40, 45).
Finally, if a lack of positive selection of surface Ig was responsible for the high frequency of in-frame joins, this
would predict that B cells should frequently express two
chains, a result that has not been observed.
The receptor editing events documented in this study
probably do not represent renewed V(D)J recombination
in mature B cells, such as has recently been described in the
germinal center (49), because the cells analyzed expressed high levels of IgM and
chain and because they
were isolated and, in the case of the hybridomas, stimulated
in a manner that should not have induced V(D)J recombination. Another indication that receptor editing in mature
B cells is unlikely to explain our results is that the fraction
of
+ cells in newly formed and mature splenic B cells is
nearly identical, suggesting that in unmanipulated mice
mature
+ cells rarely give rise to
+ B cells (44). Overall,
it would appear from our data that the RS rearrangements
that we studied were actually stimulated, rather than inhibited, by productive
gene rearrangements, probably as the
result of immune tolerance-mediated receptor editing in immature B cells. To definitively test the prediction that
the
chains of the cells that we have analyzed generate autoantibodies in association with the same cell's heavy chain,
it will be necessary to generate mice transgenic for these
genes.
| |
Footnotes |
|---|
Address correspondence to David Nemazee, The Scripps Research Institute, Mail drop IMM-29, 10550 North Torrey Pines Rd., La Jolla, CA 92037. Phone: 619-784-9528; Fax: 619-784-8805; E-mail: nemazee{at}scripps.edu
Received for publication 20 February 1998 and in revised form 22 July 1998.
We thank D. Huszar for providing JC
D/JC
D mice; B. Diamond (Albert Einstein College of Medicine,
Bronx, NY) for providing the NSO-bcl2 myeloma; S. Sobus for cell sorting; D. Norsworthy for cycle sequence analyses; D. Iklé of the Biostatistics Department for statistical analyses; K. Karjalainen and L. Wysocki
for discussions; and M. Hertz, D. Melamed, V. Kouskoff, and other members of the lab for critical reading of
the manuscript.
This work was supported by grants from the National Institutes of Health and the Arthritis Foundation.
Abbreviations used in this paper
FWR, framework region;
JC
D/+, heterozygous
deficient germline genotype;
RS, recombining sequence;
Tg, transgenic.
| |
References |
|---|
|
|
|---|
| 1. | Coleclough, C., R.P. Perry, K. Karjalainen, and M. Weigert. 1981. Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature. 290: 372-378 [Medline]. |
| 2. |
Nussenzweig, M.C.,
A.C. Shaw,
E. Sinn,
D.B. Danner,
K.L. Holmes,
H.C. Morse III, and
P. Leder.
1987.
Allelic exclusion in transgenic mice that express the membrane form of
immunoglobulin µ.
Science.
236:
816-819
|
| 3. |
Manz, J.,
K. Denis,
O. Witte,
R. Brinster, and
U. Storb.
1988.
Feedback inhibition of immunoglobulin gene rearrangement by membrane µ but not by secreted µ heavy
chains.
J. Exp. Med.
168:
1363-1381
|
| 4. |
Ritchie, K.A.,
R.L. Brinster, and
U. Storb.
1984.
Allelic exclusion and control of endogenous immunoglobulin gene rearrangement in transgenic mice.
Nature.
312:
517-520
[Medline].
|
| 5. | Storb, U. 1995. Ig gene expression and regulation in Ig transgenic mice. In Immunoglobulin Genes. Second Edition. T. Honjo and F.W. Alt, editors. Academic Press, San Diego, CA. 345-363. |
| 6. |
Gollahon, K.A.,
J. Hagman,
R.L. Brinster, and
U. Storb.
1988.
Ig -producing B cells do not show feedback inhibition of gene rearrangement.
J. Immunol.
141:
2771-2780
[Abstract].
|
| 7. |
Harada, K., and
H. Yamagishi.
1991.
Lack of feedback inhibition of V gene rearrangement by productively rearranged
alleles.
J. Exp. Med.
173:
409-415
|
| 8. |
Doglio, L.,
J.Y. Kim,
G. Bozek, and
U. Storb.
1994.
Expression of and genes can occur in all B cells and is initiated
around the same pre-B-cell developmental stage.
Dev. Immunol.
4:
13-26
[Medline].
|
| 9. | Ghia, P., A. Gratwohl, E. Signer, T.H. Winkler, F. Melchers, and A.G. Rolink. 1995. Immature B cells from human and mouse bone marrow can change their surface light chain expression. Eur. J. Immunol. 25: 3108-3114 [Medline]. |
| 10. |
Gay, D.,
T. Saunders,
S. Camper, and
M. Weigert.
1993.
Receptor editing: an approach by autoreactive B cells to escape tolerance.
J. Exp. Med.
177:
999-1008
|
| 11. |
Radic, M.Z.,
J. Erikson,
S. Litwin, and
M. Weigert.
1993.
B
lymphocytes may escape tolerance by revising their antigen
receptors.
J. Exp. Med.
177:
1165-1173
|
| 12. |
Tiegs, S.L.,
D.M. Russell, and
D. Nemazee.
1993.
Receptor
editing in self-reactive bone marrow B cells.
J. Exp. Med.
177:
1009-1020
|
| 13. | Chen, C., M.Z. Radic, J. Erikson, S.A. Camper, S. Litwin, R.R. Hardy, and M. Weigert. 1994. Deletion and editing of B cells that express antibodies to DNA. J. Immunol. 152: 1970-1982 [Abstract]. |
| 14. |
Prak, E.L.,
M. Trounstine,
D. Huszar, and
M. Weigert.
1994.
Light chain editing in -deficient animals: a potential
mechanism of B cell tolerance.
J. Exp. Med.
180:
1805-1815
|
| 15. |
Lang, J.,
M. Jackson,
L. Teyton,
A. Brunmark,
K. Kane, and
D. Nemazee.
1996.
B cells are exquisitely sensitive to central
tolerance and receptor editing induced by ultralow affinity,
membrane-bound antigen.
J. Exp. Med.
184:
1685-1697
|
| 16. |
Hertz, M., and
D. Nemazee.
1997.
BCR ligation induces receptor editing in IgM+IgD bone marrow B cells in vitro.
Immunity.
6:
429-436
[Medline].
|
| 17. |
Melamed, D., and
D. Nemazee.
1997.
Self-antigen does not
accelerate immature B cell apoptosis, but stimulates receptor
editing as a consequence of developmental arrest.
Proc. Natl.
Acad. Sci. USA.
94:
9267-9272
|
| 18. | Melamed, D., R.J. Benschop, J.C. Cambier, and D. Nemazee. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor editing. Cell. 92: 173-182 [Medline]. |
| 19. | Chen, C., E.L. Prak, and M. Weigert. 1997. Editing disease-associated autoantibodies. Immunity. 6: 97-105 [Medline]. |
| 20. | Pelanda, R., S. Schwers, E. Sonoda, R.M. Torres, D. Nemazee, and K. Rajewsky. 1997. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity. 7: 765-775 [Medline]. |
| 21. | Nemazee, D. 1995. B lymphocyte tolerance in the mouse. In Immunoglobulin Genes. Second Edition. T. Honjo and F.W. Alt, editors. Academic Press, Inc., San Diego, CA. 365-378. |
| 22. |
Feddersen, R.M., and
B.G. Van Ness.
1990.
Corrective recombination of mouse immunoglobulin kappa alleles in
Abelson murine leukemia virus-transformed pre-B cells.
Mol.
Cell. Biol.
10:
569-576
|
| 23. | Hertz, M., and D. Nemazee. 1998. Receptor editing and commitment in B lymphocytes. Curr. Opin. Immunol. 10: 208-213 [Medline]. |
| 24. |
Siminovitch, K.A.,
A. Bakhshi,
P. Goldman, and
S.J. Korsmeyer.
1985.
A uniform deleting element mediates the loss of
genes in human B cells.
Nature.
316:
260-262
[Medline].
|
| 25. |
Muller, B.,
H. Stappert, and
M. Reth.
1990.
A physical map
and analysis of the murine C -RS region show the presence
of a conserved element.
Eur. J. Immunol.
20:
1409-1411
[Medline].
|
| 26. | Daitch, L.E., M.W. Moore, D.M. Persiani, J.M. Durdik, and E. Selsing. 1992. Transcription and recombination of the murine RS element. J. Immunol. 149: 832-840 [Abstract]. |
| 27. |
Durdik, J.,
M.W. Moore, and
E. Selsing.
1984.
Novel light-chain gene rearrangements in mouse light chain-producing B lymphocytes.
Nature.
307:
749-752
[Medline].
|
| 28. |
Moore, M.W.,
J. Durdik,
D.M. Persiani, and
E. Selsing.
1985.
Deletions of chain constant region genes in mouse chain-producing B cells involve intrachromosomal DNA recombinations similar to V-J joining.
Proc. Natl. Acad. Sci.
USA.
82:
6211-6215
|
| 29. | Selsing, E., and L.E. Daitch. 1995. Immunoglobulin genes.
In Immunoglobulin Genes. Second Edition. T. Honjo and
F.W. Alt, editors. Academic Press, San Diego, CA. 193-203.
|
| 30. |
Arakawa, H.,
T. Shimizu, and
S. Takeda.
1996.
Re-evaluation of the probabilities for productive arrangements on the and loci.
Int. Immunol.
8:
91-99
|
| 31. | Nadel, B., P.A. Cazenave, and P. Sanchez. 1990. Murine lambda gene rearrangements: the stochastic model prevails over the ordered model. EMBO (Eur. Mol. Biol. Org.) J. 9: 435-440 [Medline]. |
| 32. |
Shimizu, T.,
T. Iwasato, and
H. Yamagishi.
1991.
Deletions
of immunoglobulin C region characterized by the circular
excision products in mouse splenocytes.
J. Exp. Med.
173:
1065-1072
|
| 33. |
Chen, J.,
M. Trounstine,
C. Kurahara,
F. Young,
C.C. Kuo,
Y. Xu,
J.F. Loring,
F.W. Alt, and
D. Huszar.
1993.
B cell development in mice that lack one or both immunoglobulin light chain genes.
EMBO (Eur. Mol. Biol. Organ.) J.
12:
821-830
[Medline].
|
| 34. |
Takeda, S.,
Y.R. Zou,
H. Bluethmann,
D. Kitamura,
U. Muller, and
K. Rajewsky.
1993.
Deletion of the immunoglobulin chain intron enhancer abolishes chain gene rearrangement in cis but not chain gene rearrangement in trans.
EMBO (Eur. Mol. Biol. Organ.) J.
12:
2329-2336
[Medline].
|
| 35. |
Xu, Y.,
L. Davidson,
F.W. Alt, and
D. Baltimore.
1996.
Deletion of the Ig light chain intronic enhancer/matrix attachment region impairs but does not abolish V J rearrangement.
Immunity.
4:
377-385
[Medline].
|
| 36. |
Gorman, J.R.,
N. van der Stoep,
R. Monroe,
M. Cogne,
L. Davidson, and
F.W. Alt.
1996.
The Ig 3' enhancer influences the ratio of Ig versus Ig B lymphocytes.
Immunity.
5:
241-252
[Medline].
|
| 37. | Schlissel, M.S., and D. Baltimore. 1989. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell. 58: 1001-1007 [Medline]. |
| 38. |
Ray, S., and
B. Diamond.
1994.
Generation of a fusion partner to sample the repertoire of splenic B cells destined for apoptosis.
Proc. Natl. Acad. Sci. USA.
91:
5548-5551
|
| 39. |
Kearney, J.F.,
A. Radbruch,
B. Liesegang, and
K. Rajewsky.
1979.
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.
J. Immunol.
123:
1548-1550
|
| 40. |
Retter, M.W.,
R.A. Eisenberg,
P.L. Cohen, and
S.H. Clarke.
1995.
Sm and DNA binding by dual reactive B cells
requires distinct VH, V , and VH CDR3 structures.
J. Immunol.
155:
2248-2257
[Abstract].
|
| 41. | Nemazee, D.A., and K. Burki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 337: 562-566 [Medline]. |
| 42. | Retter, M.W., P.L. Cohen, R.A. Eisenberg, and S.H. Clarke. 1996. Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. J. Immunol. 156: 1296-1306 [Abstract]. |
| 43. |
Graninger, W.B.,
P.L. Goldman,
C.C. Morton,
S.J. O'Brien, and
S.J. Korsmeyer.
1988.
The -deleting element. Germline
and rearranged, duplicated and dispersed forms.
J. Exp. Med.
167:
488-501
|
| 44. |
Zou, Y.R.,
S. Takeda, and
K. Rajewsky.
1993.
Gene targeting in the Ig locus: efficient generation of chain-expressing B cells, independent of gene rearrangements in Ig .
EMBO (Eur. Mol. Biol. Organ.) J.
12:
811-820
[Medline].
|
| 45. | Hamel, P.A., M.H. Klein, S.J. Smith-Gill, and K.J. Dorrington. 1987. Relative noncovalent association constant between immunoglobulin H and L chains is unrelated to their expression or antigen-binding activity. J. Immunol. 139: 3012-3020 [Abstract]. |
| 46. |
Kaushik, A.,
D.H. Schulze,
F.A. Bonilla,
C. Bona, and
G. Kelsoe.
1990.
Stochastic pairing of heavy-chain and light-chain variable gene families occurs in polyclonally activated B
cells.
Proc. Natl. Acad. Sci. USA.
87:
4932-4936
|
| 47. | De Lau, W.B., K. Heije, J.J. Neefjes, M. Oosterwegel, E. Rozemuller, and B.J. Bast. 1991. Absence of preferential homologous H/L chain association in hybrid hybridomas. J. Immunol. 146: 906-914 [Abstract]. |
| 48. | Radic, M.Z., M.A. Mascelli, J. Erikson, H. Shan, and M. Weigert. 1991. Ig H and L chain contributions to autoimmune specificities. J. Immunol. 146: 176-182 [Abstract]. |
| 49. |
Papavasiliou, F.,
R. Casellas,
H. Suh,
X.F. Qin,
E. Besmer,
R. Pelanda,
D. Nemazee,
K. Rajewsky, and
M.C. Nussenzweig.
1997.
V(D)J recombination in mature B cells: a mechanism for altering antibody responses.
Science.
278:
298-301
|
| 50. |
Han, S.,
S.R. Dillon,
B. Zheng,
M. Shimoda,
M.S. Schlissel, and
G. Kelsoe.
1997.
V(D)J recombinase activity in a subset
of germinal center B lymphocytes.
Science.
278:
301-305
|
| 51. |
Hikida, M., and
H. Ohmori.
1998.
Rearrangement of -light
chain genes in mature B cells in vitro and in vivo. Function
of reexpressed RAG gene products.
J. Exp. Med.
187:
795-799
|
| 52. |
Strohal, R.,
A. Helmberg,
G. Kroemer, and
R. Kofler.
1989.
Mouse V gene classification by nucleic acid sequence similarity.
Immunogenetics.
30:
475-493
[Medline].
|
This article has been cited by other articles: